ニュージャージーにおけるクローン病の臨床試験
ニュージャージー内の拠点で、クローン病に関する9件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- HMH Justice Marie Garibaldi Medical Plaza ( Site 5072), Hackensack
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Children's Hospital, Morristown
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/25更新 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Sanmora Bespoke Clinical Research Solutions LLC-Site Number: 8400123, East Orange
- Allied Health Clinical Research Organization, LLC - Freehold-Site Number: 8400014, Freehold
- Tandem-Allied Clinical Research - Somers Point-Site Number: 8400050, Somers Point
- 他1件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Childrens Hospital /ID# 256452, Morristown
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/23更新 · NCT05995353A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Atlantic Children's Health--Pediatric Gastroenterology, Morristown
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Atlantic Health - Morristown Medical Center, Morristown
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Goryeb Children's Hospital/Morristown Medical Center/Atlantic Children's Health, Morristown
被験者募集中第4相
6歳〜17歳 · 全性別 · 2026/05/27更新 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Goryeb Children's Hospital, Morristown
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/05/05更新 · NCT04779320ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。